Haben Sie sich noch nicht registriert? Hier kostenlos Ihr Konto eröffnen.
Passwort vergessen? Wir werden Ihnen einen Zurücksetzen Link senden
9 Juli 2024
Immunic Appoints Jason Tardio as Chief Operating Officer and President (news with additional features)
28 Mai 2024
Immunic to Participate in Industry and Scientific Conferences in June
8 Mai 2024
Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update
6 Mai 2024
Immunic to Participate in Investor and Scientific Conferences in May
1 Mai 2024
Immunic, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update
30 April 2024
Immunic Announces Publication of Extended Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in RRMS in the Peer Reviewed Journal, Neurology® Neuroimmunology & Neuroinflammation